Near full-length genome characterization of an HIV type 1 CRF25_cpx strain from Cameroon

AIDS Research and Human Retroviruses

Volumn 24, Issue 10, 2008, Pages 1309-1314

  Luk, Ka Cheung ^a   Holzmayer, Vera ^a   Ndembi, Nicaise ^b   Swanson, Priscilla ^a   Brennan, Catherine A ^a   Ngansop, Charlotte ^c   Mbanya, Dora ^c   Kaptué, Lazare ^b   Gürtler, Lutz ^d   Devare, Sushil G ^a   Hackett Jr , John ^a,e  

^a ABBOTT DIAGNOSTICS   (United States)

^b Université des Montagnes ^*  (Cameroon)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^d GOETHE UNIVERSITY   (Germany)

^e ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; CAMEROON; GENETIC ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRUS STRAIN;

CAMEROON; CLUSTER ANALYSIS; GENOME, VIRAL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY;

EID: 53849138758     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0124     Document Type: Article

References (12)

1. Osmanov S, Pattou C, Walker N, Schwartländer B, Esparza J, and the WHO-UNAIDS Network for HIV Isolation and Characterization: Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002;29:184-190.
2. Buonaguro L, Tornesello ML, and Buonaguro FM: Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: Pathogenetic and therapeutic implications. J Virol 2007;81:10209-10219.
3. Gueudin M, Plantier JC, Lemée V, Schmitt MP, Chartier L, Bourlet T, Ruffault A, Damond F, Vray M, and Simon F: Evaluation of the Roche Cobas TaqMan and Abbott Real-Time Extraction-Quantification Systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007;44:500-505.
4. Taylor BS, Sobieszczyk ME, McCutchan FE, and Hammer SM: The challenge of HIV-1 subtype diversity. N Engl J Med 2008;358:1590-1602.
5. Brennan CA, Bodelle P, Coffey R, Harris B, Holzmayer V, Luk K-C, Swanson P, Yamaguchi J, Vallari A, Devare SG, Schochetman G, and Hackett J Jr: HIV global surveillance: Foundation for retroviral discovery and assay development. J Med Virol 2006;78:S24-S29.
6. Swanson P, Devare SG, and Hackett J Jr: Molecular characterization of 39 HIV-1 isolates representing group M (subtypes A-G) and group O: Sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res Hum Retroviruses 2003;19:625-629.
7. Harris B, von Truchsess I, Schätzl HM, Devare SG, and Hackett J Jr: Genomic characterization of a novel HIV type 1 B/G intersubtype recombinant strain from an injecting drug user in Germany. AIDS Res Hum Retroviruses 2005;21:654-660.
8. Luk K, Holzmayer V, Yamaguchi J, Swanson P, Brennan C, Ngansop C, Mbanya D, Gayum H, Djuidje M, Ndembi N, Kamdem D, Kaptue L, Gurtler L, Devare S, and Hackett J Jr: Near full-length genome characterization of three additional HIV type 1 CRF13_cpx strains from Cameroon. AIDS Res Hum Retroviruses 2007;23:297-302.
9. Peeters M: Recombinant HIV sequences: Their role in the global epidemic. In: Human Retroviruses and AIDS 2000: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Kuiken C, Foley B, Hahn B, et al., eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2000, pp. 39-54.
10. Ndembi N, Takehisa J, Zekeng L, Kobayashi E, Ngansop C, Songok EM, Kageyama S, Takemura T, Ido E, Hayami M, Kaptue L, and Ichimura H: Genetic diversity of HIV type 1 in rural eastern Cameroon. J Acquir Immune Defic Syndr 2004;37:1641-1650.
11. Yamaguchi J, Badreddine S, Swanson P, Bodelle P, Devare SG, and Brennan CA: Identification of new CRF43_02G and CRF25_cpx in Saudi Arabia based on full genome sequence analysis of six HIV-1 isolates. AIDS Res Hum Retroviruses 2008;24 (in press).
12. Garrido C, Zahonero N, Fernandes D, Serrano D, Silva A, Ferraria N, Antunes F, Gonzalez-Lahoz J, Soriano V, and De Mendoza C: Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola. J Antimicrob Chemother 2008;61:694-698.